Can nose cells unlock the secrets of respiratory viruses?

NCT ID NCT06120244

Recruiting now Knowledge-focused Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Source: ClinicalTrials.gov ↗

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This study collects cell samples from the inside of healthy volunteers' noses to create a biobank for future research on respiratory viruses. The goal is to better understand how these viruses infect the nose, travel to the lungs, and spread between people. Healthy adults aged 18 and older provide a simple nasal swab during a single visit. The stored samples may help develop organoids and validate lab tests for studying emerging respiratory threats.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nasal epithelium brush sampling (non-invasive cell collection)
What this could lead to: If successful, this biobank could help researchers understand how respiratory viruses infect the nose and spread to the lungs, potentially guiding future treatments or vaccines.
What could go wrong: This is an early-stage sample collection study, not a treatment trial. The samples may not fully represent how viruses behave in real infections, and future research using them may not yield immediate breakthroughs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY

Contacts and locations

Locations

Rocky Mountain Laboratories
RECRUITING

Hamilton, Montana, 59840, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.